Implementation of Precision Medicine in High-risk Prostate Cancer

Launched by ANDREAS JOSEFSSON · Nov 12, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding prostate cancer better, particularly for men who are at high risk or have advanced stages of the disease. The study aims to take a close look at the genetic makeup of prostate tumors to find specific markers that can help doctors predict how well a patient might respond to different treatments. By doing this, the researchers hope to improve personalized treatment plans for men with prostate cancer.

To participate in this study, you need to be a man aged between 65 and 74 who has been evaluated for suspected prostate cancer and is willing to sign a consent form. If you have trouble understanding the study information for any reason, you may not be eligible. If you join the trial, you will provide samples for testing, and your tumor will be analyzed, but you won’t receive any treatment from the study itself. This research is important as it could lead to better treatment options tailored to individual patients in the future.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Men investigated for suspected prostate cancer
• • Signed consent form
• Exclusion Criteria:
• • Difficulties understanding information about the study due to linguistic, cognitive or other reason